Article Cited by others


Limitations and obstacles of the spontaneous adverse drugs reactions reporting: Two "challenging" case reports

Palleria Caterina, Leporini Christian, Chimirri Serafina, Marrazzo Giuseppina, Sacchetta Sabrina, Bruno Lucrezia, Lista Rosaria M, Staltari Orietta, Scuteri Antonio, Scicchitano Francesca, Russo Emilio

Year : 2013| Volume: 4| Issue : 5 | Page no: 66-72

   This article has been cited by
1 Evaluation of the Association between Topical Prostaglandin F2a Analogs and Asthma Using the JADER Database: Comparison with ß-Blockers
Katsuhiro Ohyama,Munetoshi Sugiura
YAKUGAKU ZASSHI. 2018; 138(4): 559
[Pubmed]  [Google Scholar] [DOI]
2 Frequent discussion of insomnia and weight gain with glucocorticoid therapy: an analysis of Twitter posts
Rikesh Patel,Maksim Belousov,Meghna Jani,Nabarun Dasgupta,Carly Winakor,Goran Nenadic,William G. Dixon
npj Digital Medicine. 2017; 1(1)
[Pubmed]  [Google Scholar] [DOI]
3 Predicting Drug-Induced Cholestasis with the Help of Hepatic Transporters—An in Silico Modeling Approach
Eleni Kotsampasakou,Gerhard F. Ecker
Journal of Chemical Information and Modeling. 2017; 57(3): 608
[Pubmed]  [Google Scholar] [DOI]
4 The key role of clinical and community health nurses in pharmacovigilance
Caterina Bigi,Guido Bocci
European Journal of Clinical Pharmacology. 2017;
[Pubmed]  [Google Scholar] [DOI]
5 Predicting drug-induced liver injury: the importance of data curation
Eleni Kotsampasakou,Floriane Montanari,Gerhard F. Ecker
Toxicology. 2017;
[Pubmed]  [Google Scholar] [DOI]
6 Safety of Antiplatelet Agents: Analysis of ‘Real-World’ Data from the Italian National Pharmacovigilance Network
Lucia Gozzo,Andrea Navarria,Giuseppe Benfatto,Laura Longo,Silvana Mansueto,Laura Sottosanti,Luca Pani,Salvatore Salomone,Filippo Drago
Clinical Drug Investigation. 2017;
[Pubmed]  [Google Scholar] [DOI]
7 Public confidence in ADR identification and their views on ADRreporting: mixed methods study
Narumol Jarernsiripornkul,Arunrot Patsuree,Janet Krska
European Journal of Clinical Pharmacology. 2016;
[Pubmed]  [Google Scholar] [DOI]
8 Monitoring safety and use of old and new treatment options for type 2 diabetic patients: a two-year (2013–2016) analysis
Christian Leporini,Rosanna Piro,Francesco Ursini,Francesca Maida,Caterina Palleria,Franco Arturi,Maria Pavia,Giovambattista De Sarro,Emilio Russo
Expert Opinion on Drug Safety. 2016; 15(sup2): 17
[Pubmed]  [Google Scholar] [DOI]
9 Differences in VigiBase® reporting of aminoglycoside and capreomycin-suspected ototoxicity during tuberculosis treatment
Evans L. Sagwa,Patrick C. Souverein,Inęs Ribeiro,Hubert G. M. Leufkens,Aukje K. Mantel-Teeuwisse
Pharmacoepidemiology and Drug Safety. 2016;
[Pubmed]  [Google Scholar] [DOI]
10 Is safety of childhood growth hormone therapy related to dose? Data from a large observational study
Lars Sävendahl,Effie Pournara,Birgitte Třnnes Pedersen,Oliver Blankenstein
European Journal of Endocrinology. 2016; 174(5): 681
[Pubmed]  [Google Scholar] [DOI]
11 Adherence to therapy and adverse drug reactions: is there a link?
Christian Leporini,Giovambattista De Sarro,Emilio Russo
Expert Opinion on Drug Safety. 2014; 13(S1): 41
[Pubmed]  [Google Scholar] [DOI]


Read this article